0078-0708 : Piqray 150 mg Oral Tablet
| NDC: | 0078-0708 |
| Labeler: | Novartis Pharmaceuticals Corporation |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Piqray |
| Dosage Form: | Oral Tablet |
| Application #: | NDA212526 |
| Rev. Date: |
Appearance:
| Markings: | UL7;NVR |
| Shapes: |
Oval |
| Colors: |
 Red |
| Size (mm): | 14 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 0078-0708-02: 2 BLISTER PACK IN 1 CARTON (0078‑0708‑02) > 28 TABLET IN 1 BLISTER PACK (0078‑0708‑51)
- 0078-0708-91: 1 BLISTER PACK IN 1 CARTON (0078‑0708‑91) > 28 TABLET IN 1 BLISTER PACK (0078‑0708‑90)
Active Ingredients:
- Alpelisib
Dosage Strength:
- 150 mg
Inactive Ingredients:
- Cellulose, Microcrystalline
- Mannitol
- Sodium Starch Glycolate Type a Potato
- Hypromellose, Unspecified
- Magnesium Stearate
- Talc
- Polyethylene Glycol 4000
- Titanium Dioxide
- Ferric Oxide Red
- Ferrosoferric Oxide /
Related Products:
Based on records with the same trade name.- 0078-0701 Piqray 200 mg Oral Tablet by Novartis Pharmaceuticals Corporation
- 0078-0715 PiqrayPiqray Kit by Novartis Pharmaceuticals Corporation
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0078-0701Next: 0078-0709 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.